Рет қаралды 697
In this video we look into the latest draft guidelines released by the CDSCO and understand the key focus areas that impact the clinical trial and pharma industry as well as policy improvements and mandates proposed by the CDSCO in this guidelines.
#cdsco #regulatory #guidelines #india #dcgi #fda #regulatoryagency #cosmetics #pharmaceuticals #medicaldevices #ndct #drugs #clinicaltrials #pharmacy #draft
⚠️ Links to most helpful videos ⚠️
NDCT Rules 2019: • New Drugs and Clinical...
SAE reporting and SUGAM: • Serious Adverse events...
Adverse events (AE) in Clinical Trials: • Adverse Events & Adver...
CRA Interview: • CRA Interview Question...
CRC interview: • CRC Interview Question...
Clinical Research Coordinator: • Clinical Research Coor...
Clinical Research explained under 5 mins: • How to start a Career ...
13 Principle of ICH-GCP: • 13 principles of ICH G...
CRC or CRA: • Starting Clinical Rese...
Phases of Clinical trials: • What are Phase trials?...
Good Clinical Practices (ICH-GCP): • Good Clinical Practice...
Ethics Committee in Clinical Research: • Ethics committee in Cl...
For queries about Advanced Certification in Clinical Research, please reach out/contact at below mentioned platforms
Contact: +91 77219 76079 / 83900 88032
To Register, please click on the link below:
docs.google.co...
Instagram ID: clinical_aim_research
Gmail: clinicalaimresearch@gmail.com
For any queries, kindly comment in the description box below.
In this video, We explain about:
(0:00) Intro
(0:45) CDSCO releases draft guidelines
(1:50) Key Focus Areas
(5:18) What does sponsor needs to know?
(9:20) Guideline Impact